Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis.

Mankia K, Cheng Z, Do T, Hunt L, Meade J, Kang J, Clerehugh V, Speirs A, Tugnait A, Hensor EMA, Nam JL, Devine DA, Emery P.

JAMA Netw Open. 2019 Jun 5;2(6):e195394. doi: 10.1001/jamanetworkopen.2019.5394.

2.

Enrichment of periodontal pathogens from the biofilms of healthy adults.

Naginyte M, Do T, Meade J, Devine DA, Marsh PD.

Sci Rep. 2019 Apr 2;9(1):5491. doi: 10.1038/s41598-019-41882-y.

3.

Insulin-Like Growth Factor Axis Expression in Dental Pulp Cells Derived From Carious Teeth.

Alkharobi HE, Al-Khafaji H, Beattie J, Devine DA, El-Gendy R.

Front Bioeng Biotechnol. 2018 Apr 12;6:36. doi: 10.3389/fbioe.2018.00036. eCollection 2018.

4.

Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis.

Cheng Z, Meade J, Mankia K, Emery P, Devine DA.

Best Pract Res Clin Rheumatol. 2017 Feb;31(1):19-30. doi: 10.1016/j.berh.2017.08.001. Epub 2017 Sep 1. Review.

5.

Novel methodology for determining the effect of adsorbates on human enamel acid dissolution.

Pechlivani N, Devine DA, Marsh PD, Mighell A, Brookes SJ.

Arch Oral Biol. 2018 Jan;85:46-50. doi: 10.1016/j.archoralbio.2017.09.035. Epub 2017 Oct 3.

6.

Influence of saliva on the oral microbiota.

Marsh PD, Do T, Beighton D, Devine DA.

Periodontol 2000. 2016 Feb;70(1):80-92. doi: 10.1111/prd.12098. Review.

7.

Ecological approaches to oral biofilms: control without killing.

Marsh PD, Head DA, Devine DA.

Caries Res. 2015;49 Suppl 1:46-54. doi: 10.1159/000377732. Epub 2015 Apr 13. Review.

8.

Modulation of host responses by oral commensal bacteria.

Devine DA, Marsh PD, Meade J.

J Oral Microbiol. 2015 Feb 6;7:26941. doi: 10.3402/jom.v7.26941. eCollection 2015.

9.

Part 1: Evidence-based facility design using Transforming Care at the Bedside principles.

Devine DA, Wenger B, Krugman M, Zwink JE, Shiskowsky K, Hagman J, Limon S, Sanders C, Reeves C.

J Nurs Adm. 2015 Feb;45(2):74-83. doi: 10.1097/NNA.0000000000000161.

PMID:
25621749
10.

Prospects of oral disease control in the future - an opinion.

Marsh PD, Head DA, Devine DA.

J Oral Microbiol. 2014 Nov 27;6:26176. doi: 10.3402/jom.v6.26176. eCollection 2014.

11.

Non-lethal control of the cariogenic potential of an agent-based model for dental plaque.

Head DA, Marsh PD, Devine DA.

PLoS One. 2014 Aug 21;9(8):e105012. doi: 10.1371/journal.pone.0105012. eCollection 2014.

12.

The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Al-Kharobi H, El-Gendy R, Devine DA, Beattie J.

Cell Mol Life Sci. 2014 Apr;71(8):1469-76. Review.

PMID:
24232361
13.

How is the development of dental biofilms influenced by the host?

Marsh PD, Devine DA.

J Clin Periodontol. 2011 Mar;38 Suppl 11:28-35. doi: 10.1111/j.1600-051X.2010.01673.x. Review.

PMID:
21323701
14.

Dental plaque biofilms: communities, conflict and control.

Marsh PD, Moter A, Devine DA.

Periodontol 2000. 2011 Feb;55(1):16-35. doi: 10.1111/j.1600-0757.2009.00339.x. Review. No abstract available.

PMID:
21134226
15.

Control of microbial contamination in dental unit water systems using tetra-sodium EDTA.

Percival RS, Devine DA, Nattress B, Kite P, Marsh PD.

J Appl Microbiol. 2009 Oct;107(4):1081-8. doi: 10.1111/j.1365-2672.2009.04299.x. Epub 2009 Apr 9.

16.

Prospects for the development of probiotics and prebiotics for oral applications.

Devine DA, Marsh PD.

J Oral Microbiol. 2009 May 1;1. doi: 10.3402/jom.v1i0.1949.

17.

The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.

Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE.

Infect Immun. 2008 Sep;76(9):4163-75. doi: 10.1128/IAI.00188-08. Epub 2008 Jul 14.

18.

In vitro susceptibility of the Streptococcus milleri group to antimicrobial peptides.

Bartie KL, Devine DA, Wilson MJ, Lewis MA.

Int Endod J. 2008 Jul;41(7):586-92. doi: 10.1111/j.1365-2591.2008.01404.x. Epub 2008 May 12.

PMID:
18479375
19.

Host defense peptides in the oral cavity.

Devine DA, Cosseau C.

Adv Appl Microbiol. 2008;63:281-322. doi: 10.1016/S0065-2164(07)00008-1. Review. No abstract available.

PMID:
18395131
20.

Inhibition of biofilms associated with dentures and toothbrushes by tetrasodium EDTA.

Devine DA, Percival RS, Wood DJ, Tuthill TJ, Kite P, Killington RA, Marsh PD.

J Appl Microbiol. 2007 Dec;103(6):2516-24.

21.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

22.

The effect of cocoa polyphenols on the growth, metabolism, and biofilm formation by Streptococcus mutans and Streptococcus sanguinis.

Percival RS, Devine DA, Duggal MS, Chartron S, Marsh PD.

Eur J Oral Sci. 2006 Aug;114(4):343-8.

PMID:
16911106
23.

Penetration of fluoride into natural plaque biofilms.

Watson PS, Pontefract HA, Devine DA, Shore RC, Nattress BR, Kirkham J, Robinson C.

J Dent Res. 2005 May;84(5):451-5.

PMID:
15840782
24.

SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype.

Bingle L, Cross SS, High AS, Wallace WA, Devine DA, Havard S, Campos MA, Bingle CD.

J Pathol. 2005 Mar;205(4):491-7.

PMID:
15685591
25.

Minimizing prion risk without compromising the microbial composition of biofilms grown in vivo in a human plaque model.

Watson PS, Sissons CH, Devine DA, Shore RC, Kirkham J, Nattress BR, Marsh PD, Robinson C.

Lett Appl Microbiol. 2004;38(3):211-6.

26.

Antimicrobial peptides in defence of the oral and respiratory tracts.

Devine DA.

Mol Immunol. 2003 Nov;40(7):431-43. Review.

PMID:
14568389
27.

Cationic peptides: distribution and mechanisms of resistance.

Devine DA, Hancock RE.

Curr Pharm Des. 2002;8(9):703-14. Review.

PMID:
11945166
28.

Ultraviolet disinfection with a novel microwave-powered device.

Devine DA, Keech AP, Wood DJ, Killington RA, Boyes H, Doubleday B, Marsh PD.

J Appl Microbiol. 2001 Nov;91(5):786-94.

29.

Genetic heterogeneity in Prevotella intermedia, Prevotella nigrescens, Prevotella corporis and related species isolated from oral and nonoral sites.

Pearce MA, Devine DA, Dixon RA, van Steenbergen TJ.

Oral Microbiol Immunol. 2000 Apr;15(2):89-95.

PMID:
11155171
30.
31.

Expression of beta-defensin genes by human salivary glands.

Bonass WA, High AS, Owen PJ, Devine DA.

Oral Microbiol Immunol. 1999 Dec;14(6):371-4.

PMID:
10895693
32.

Identification of ragAB as a temperature-regulated operon of Porphyromonas gingivalis W50 using differential display of randomly primed RNA.

Bonass WA, Marsh PD, Percival RS, Aduse-Opoku J, Hanley SA, Devine DA, Curtis MA.

Infect Immun. 2000 Jul;68(7):4012-7.

33.

Trefoil factor expression in normal and diseased human salivary glands.

Devine DA, High AS, Owen PJ, Poulsom R, Bonass WA.

Hum Pathol. 2000 Apr;31(4):509-15.

PMID:
10821500
34.

Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp.

Devine DA, Marsh PD, Percival RS, Rangarajan M, Curtis MA.

Microbiology. 1999 Apr;145 ( Pt 4):965-71.

PMID:
10220176
35.

Influence of sample preparation technique on two-dimensional gel electrophoresis of proteins from Porphyromonas gingivalis.

Pridmore AM, Devine DA, Bonass WA, Silley P.

Lett Appl Microbiol. 1999 Apr;28(4):245-9.

36.

Effect of temperature on growth, hemagglutination, and protease activity of Porphyromonas gingivalis.

Percival RS, Marsh PD, Devine DA, Rangarajan M, Aduse-Opoku J, Shepherd P, Curtis MA.

Infect Immun. 1999 Apr;67(4):1917-21.

37.

Optimized oligonucleotides for the differentiation of Prevotella intermedia and Prevotella nigrescens.

Conrads G, Pelz K, Hughes B, Seyfarth I, Devine DA.

Oral Microbiol Immunol. 1997 Apr;12(2):117-20.

PMID:
9227136
38.
39.

Antimicrobial activity of cecropins.

Moore AJ, Beazley WD, Bibby MC, Devine DA.

J Antimicrob Chemother. 1996 Jun;37(6):1077-89.

PMID:
8836811
40.

Extraction of the synthetic lytic peptide, cecropin B, from biological fluid and analysis using reversed-phase high-performance liquid chromatography.

Moore AJ, Loadman PM, Devine DA, Bibby MC.

J Chromatogr B Biomed Appl. 1995 Oct 20;672(2):225-31.

PMID:
8581128
41.

Preliminary experimental anticancer activity of cecropins.

Moore AJ, Devine DA, Bibby MC.

Pept Res. 1994 Sep-Oct;7(5):265-9.

PMID:
7849420
42.
43.

Species-specificity of monoclonal antibodies recognising Prevotella intermedia and Prevotella nigrescens.

Devine DA, Pearce MA, Gharbia SE, Shah HN, Dixon RA, Gmür R.

FEMS Microbiol Lett. 1994 Jul 1;120(1-2):99-104.

PMID:
8056301
44.

Characterization of Prevotella intermedia and Prevotella nigrescens isolates from periodontic and endodontic infections.

Gharbia SE, Haapasalo M, Shah HN, Kotiranta A, Lounatmaa K, Pearce MA, Devine DA.

J Periodontol. 1994 Jan;65(1):56-61.

PMID:
7907659
45.

Simple technique for detecting K1 antigen of Escherichia coli.

Devine DA, Roberts AP, Rowe B.

J Clin Pathol. 1990 Jan;43(1):76-8.

46.
47.

Ultrastructure, serogrouping and localization of surface antigens of Bacteroides intermedius.

Devine DA, Gmür R, Handley PS.

J Gen Microbiol. 1989 Apr;135(4):967-79.

PMID:
2480991
48.

Selection of a dye for use in semen transport studies in the cow.

Devine DA, Isbister J, Lindsay FE, Boyd H.

Theriogenology. 1986 Mar;25(3):445-50.

PMID:
16726135
49.

Hysteroscopy in the cow using a flexible fibrescope.

Devine DA, Lindsay FE.

Vet Rec. 1984 Dec 15;115(24):627-8. No abstract available.

PMID:
6523704
50.

Outcome effects of receiving a preferred, randomly assigned, or nonpreferred therapy.

Devine DA, Fernald PS.

J Consult Clin Psychol. 1973 Aug;41(1):104-7. No abstract available.

PMID:
4737768

Supplemental Content

Loading ...
Support Center